Follow
Desiree Schenk
Desiree Schenk
Gritstone bio
Verified email at gritstone.com
Title
Cited by
Cited by
Year
Microporous polyphenylenes with tunable pore size for hydrogen storage
S Yuan, B Dorney, D White, S Kirklin, P Zapol, L Yu, DJ Liu
Chemical communications 46 (25), 4547-4549, 2010
2262010
Genotype–phenotype associations and human eye color
D White, M Rabago-Smith
Journal of human genetics 56 (1), 5-7, 2011
1512011
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
CD Palmer, AR Rappaport, MJ Davis, MG Hart, CD Scallan, SJ Hong, ...
Nature medicine 28 (8), 1619-1629, 2022
612022
Porous organic polymers containing carborane for hydrogen storage
S Yuan, D White, A Mason, DJ Liu
International journal of energy research 37 (7), 732-740, 2013
322013
Design and assessment of a wrapped cylindrical Ca‐P AZ31 Mg alloy for critical‐size ulna defect repair
MR Smith, P Atkinson, D White, T Piersma, G Gutierrez, G Rossini, ...
Journal of Biomedical Materials Research Part B: Applied Biomaterials 100 (1 …, 2012
322012
Nanomedicine strategies for treatment of secondary spinal cord injury
D White-Schenk, R Shi, JF Leary
International journal of nanomedicine, 923-938, 2015
312015
Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2
D Schenk, G Song, Y Ke, Z Wang
PLoS One 12 (7), e0181062, 2017
292017
Improving hydrogen adsorption enthalpy through coordinatively unsaturated cobalt in porous polymers
S Yuan, D White, A Mason, B Reprogle, MS Ferrandon, L Yu, DJ Liu
Macromolecular rapid communications 33 (5), 407-413, 2012
182012
Kinetics and mechanistic studies on the reaction between cytochrome c and tea catechins
L Wang, E Santos, D Schenk, M Rabago-Smith
Antioxidants 3 (3), 559-568, 2014
162014
Personalized viral-based prime/boost immunotherapy targeting patient-specific or shared neoantigens: Immunogenicity, safety, and efficacy results from two ongoing phase I studies.
CG Drake, ML Johnson, AI Spira, GA Manji, DP Carbone, BS Henick, ...
Journal of Clinical Oncology 38 (15_suppl), 3137-3137, 2020
92020
960MO Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC
DV Catenacci, CY Liao, S Maron, BJ Solomon, A Mahipal, ML Johnson, ...
Annals of Oncology 32, S830-S831, 2021
62021
736Mo personalized, off-the-shelf KRAS Neoantigen-specific Immunotherapy for the treatment of advanced solid tumors: clinical benefit associated with decreases in ctDNA (SLATE …
CK Kyi, A Spira, DP Carbone, ML Johnson, BS Henick, B Johnson, ...
Annals of Oncology 33, S880, 2022
52022
Mesoporous silica nanoparticles for treating spinal cord injury
D White-Schenk, R Shi, JF Leary
Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XI …, 2013
52013
Target capture and barcoding in monodisperse droplets
R Meltzer, K Fontanez, D Schenk, Y Xue
US Patent App. 17/281,157, 2021
22021
Hairpin primer design for sequential pcr production of targeted sequencing libraries
R Meltzer, K Fontanez, D Schenk
US Patent App. 16/998,685, 2021
22021
Mediating the potent ROS toxicity of acrolein in neurons involved in secondary spinal cord injury with silica nanoparticles and a natural product approach
D White-Schenk, R Shi, JF Leary
89560C-89560C–11, 2014
22014
659 COM701 plus nivolumab demonstrates preliminary antitumor activity and immune modulation of tumor microenvironment in patients with metastatic MSS-CRC and liver metastases
D Rasco, E Dumbrava, M Sharma, D Shepard, D Vaena, G Fleming, ...
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
12022
Cell-free dna monitoring
JX Sun, MJ Davis, D Schenk, DN Gomez
US Patent App. 17/861,088, 2023
2023
Disease monitoring with comprehensive genomics provides evidence of mechanism of action and immune evasion in patients receiving an individualized neoantigen cancer vaccine
D Schenk, R Zhou, O Petrillo, A Mantilla, IF do Valle, S Maron, BS Henick, ...
Cancer Research 83 (7_Supplement), 1126-1126, 2023
2023
660 Clinicopathologic characteristics of patients with metastatic colorectal cancer with molecular responses following treatment with an individualized neoantigen vaccine regimen
CY Liao, B Johnson, A Spira, D Carbone, B Henick, M Overman, B Polite, ...
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20